Takeda Pharmaceutical's new AI-crafted treatment for plaque psoriasis, zasocitinib, has demonstrated strong efficacy in ...
Patients with moderate-to-severe plaque psoriasis who took the once-daily pill showed significantly clearer skin compared with those on placebo or the existing therapy apremilast, the company said.
Students for Life of America (SFLA) is calling on the Environmental Protection Agency (EPA) to add the abortion drug ...
A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A new experimental drug from ...
If approved, zasocitinib would stand out as one of the first drugs discovered with the help of artificial intelligence.
Mumbai: A 45-year-old man has been arrested within six hours for allegedly raping multiple girls in Mumbai after mixing ...
Takeda Pharmaceutical Co. rose the most in seven months on Friday after the drugmaker said its oral psoriasis drug zasocitinib proved safe and effective in late-stage trials, marking a milestone in ...
ScienceAlert on MSN
14 Psychiatric Disorders Share 5 Genetic Roots, Major Study Reveals
We know that the genes we're born with contribute to the risk of psychiatric disorders during our lifetimes, and a new study ...
For decades, the FDA made it nearly impossible to know which factories were manufacturing your generic medications.
In a renewed push to safeguard India's malaria treatment protocols, the Drugs Controller General of India (DCGI) has directed ...
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, ...
Early Thursday, Takeda revealed top-line data for two pivotal phase 3 trials of its next-gen, highly selective oral tyrosine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results